Purchase Order 75N91022P00675
- Not listed
- This $507,000 firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a German non-profit organization focused on cancer research. The contract requires DKFZ to test no more than 13,000 samples previously collected in the Anchor Trial using a multiplex serology assay of up to 41 antigens. The work is to be performed at DKFZ's facilities in Heidelberg, Germany, with...
- The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB) awarded a $397,800.00 firm fixed-price purchase order contract to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation based in Germany. The contract, which does not have a set-aside designation, is for the testing of various elements related to...
- This is a $35,239.68 firm fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a non-profit cancer research organization based in Germany. The contract is for HPV serology testing services, which aligns with DKFZ's expertise in cancer research, diagnostics, and testing. The contract does not have a set-aside designation, indicating it was awarded through open competition....
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization based in Germany. The contract is for "OTHER FUNCTIONS OPTION PERIOD ONE (1): ADDITIONAL SAMPLES FOR HPV SEROLOGY" with a ceiling value of $37,407.15. The contract does not have a set-aside designation, indicating open competition. DKFZ, also known as Dkfz, is...
- <p>The National Cancer Institute awarded a purchase order to Deutsches Krebsforschungszentrum (DKFZ) valued at $20,026.05 on August 21, 2017, for HPV serologic testing in support of a prospective study evaluating HPV prior to diagnosis of incident head and neck cancer and anogenital cancer. Work is performed in Germany under firm fixed price terms, with completion targeted for August 31, 2018. No set-aside was applied to this procurement.</p>
- The National Cancer Institute awarded a purchase order to Deutsches Krebsforschungszentrum on September 17, 2018, for serum sample handling and HPV serologic and multiplex serology testing, with a total ceiling value of $180,843.00. This modification exercised an optional Phase 2 task under CLIN 10, obligating $19,790.00 and increasing the total obligated amount from $161,053.00. Work is performed in Germany on a firm fixed-price basis, with an ultimate completion date of September 16, 2020....
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation, to conduct a study testing for possible relationships between gynecologic infections and endometrial cancer in serum samples from a previous study in Poland. The potential value of the contract is $105,816.00, and the period of performance runs from the award...
- <p>The National Cancer Institute awarded a purchase order to Deutsches Krebsforschungszentrum on September 18, 2017, with a ceiling value of $18,876.00 under firm fixed-price terms. Performance is located in Germany, with an ultimate completion date of September 24, 2018. The procurement was issued under open competition with no set-aside designation.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation, to provide services for the collection, harmonization, and management of breast cancer risk factor data being contributed to the Confluence Project from the Breast Cancer Association Consortium (BCAC). The base period of performance for this contract is from September...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,407 purchase order to Engene Statistics Sagl of Switzerland for testing services. Under the firm fixed price contract, Engene Statistics Sagl will provide unspecified testing services to the National Cancer Institute from July 31, 2023 through October 31, 2023. The contract was awarded directly to Engene Statistics Sagl as the prime contractor, with no mention of major...
This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, to the non-profit organization Deutsches Krebsforschungszentrum (DKFZ) to provide multiplex serology testing of antigens for plasma samples. The $119,840 contract is intended to assist with understanding Epstein-Barr virus (EBV) antibody-based nasopharyngeal cancer (NPC) risk scores in Asian population cohorts. The contract does not have a set-aside designation and is scheduled for completion by July 31, 2023. DKFZ, a foundation that provides various cancer-related testing, data, and research services to U.S. federal agencies, has previously received prime contracts and subcontracts from the Department of Health and Human Services, National Institutes of Health, and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.8k | 7/29/22 |